新华品牌怎么样 申请店铺

我要投票 新华在医疗器械行业中的票数:322 更新时间:2025-07-22
新华是哪个国家的品牌?「新华」是 山东新华医疗器械股份有限公司 旗下著名品牌。该品牌发源于山东省淄博市,由创始人许尚峰在1943年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力新华品牌出海!将品牌入驻外推网,定制新华品牌推广信息,可以显著提高新华产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

新华怎么样


山东新华医疗器械股份有限公司座落于山东淄博高新区。淄博是“中国陶瓷名城”,位于山东中部鲁中山地与鲁北平原的交接地带,南连泰山,北靠黄河,东临海滨旅游城市青岛,西接泉城济南,是中华民族古老文明的发祥地之一,开创了"泱泱大风"的齐国文化,被誉为"海内名都"。

新华医疗创建于1942年,是我党我军创建的第一家医疗器械生产企业,现为国家医疗器械行业协会会长单位,消毒供应室设备专业委员会理事长、秘书长单位,被国家定名为消毒灭菌设备研制中心。新华医疗是集产品设计、研发、生产、销售于一体的大型综合性企业,现拥有生产工厂6家、子公司6家;员工2300多人,其中工程技术人员500多人。

产品主要分为九大类:感染控制产品、灭菌检测产品、放射治疗产品、x射线诊断产品、制药装备、手术器械、一次性医用耗材、空气净化产品、医用环保设备。其中消毒灭菌、制药装备、放射治疗三类产品的规模、技术水平居全国第一。XHA600型医用电子直线加速器获得“国家自主创新产品证书”。

2002年,公司在上海证券交易所成功上市。经过不懈的努力,新华医疗成为了第一家在医疗器械行业中拥有国家级企业技术中心和唯一的“AAAA”级标准化良好行为的企业,2009年“新华医疗”被国家工商总局认定为“中国驰名商标”。近几年公司承担了6项国家火炬计划,拥有13项国家2级新产品,300多项国家专利证书,获得多项省市级科技进步奖,并通过了ISO9001、ISO13485、CE等质量体系认证。

公司在发展过程中得到了各级政府和领导的大力支持和关心,胡锦涛总书记,温家宝总理,王兆国、李建国副委员长等国家领导人先后来公司视察工作。2009年10月17日胡锦涛总书记来到新华医疗视察工作。胡总书记对新华医疗的自主创新表示赞赏,并勉励员工继续奋发进取,不断推进技术创新、管理创新、服务创新,使企业永葆生机活力。2009年6月27日温家宝总理来到新华医疗视察指导,温总理指出,国家会继续加强人民群众医疗卫生保障能力。温总理希望新华医疗更快更好的发展,为人民群众的医疗事业做出更大的贡献。

新华医疗以“心系健康,诚信天下”为企业理念,以客户的满意为我们的追求。产品销售和服务网络覆盖全国所有省市、自治区、直辖市,并远销欧美、中东等70多个国家和地区。

“行远必自迩,追求无止境”。新华医疗将一如既往的与时俱进,为人类健康事业做出贡献,为铸造中国医疗器械产业的丰碑而不断进取!


Shandong Xinhua Medical Equipment Co., Ltd. is located in Shandong Zibo High tech Zone. Zibo is a "famous city of Chinese ceramics", located in the junction of the central Shandong mountain and the northern Shandong plain, with Mount Tai in the south, the Yellow River in the north, Qingdao as a coastal tourist city in the East, Jinan as a spring city in the West. It is one of the birthplaces of the ancient Chinese civilization, creating the Qi culture of "great wind", known as the "famous capital in the sea". Xinhua medical, founded in 1942, is the first medical device manufacturer established by our party and our army. It is now the chairman unit of the National Medical Device Industry Association, the director general and secretary general unit of the professional committee of disinfection and supply room equipment, and is named the center of disinfection and sterilization equipment development by the state. Xinhua medical is a large-scale comprehensive enterprise integrating product design, R & D, production and sales. Now it has 6 production plants and 6 subsidiaries, more than 2300 employees, including more than 500 engineering and technical personnel. The products are mainly divided into nine categories: infection control products, sterilization testing products, radiotherapy products, X-ray diagnostic products, pharmaceutical equipment, surgical instruments, disposable medical consumables, air purification products, medical environmental protection equipment. Among them, the scale and technical level of disinfection and sterilization, pharmaceutical equipment and radiotherapy products rank first in China. Xha600 medical linear accelerator has obtained the "national independent innovation product certificate". In 2002, the company was successfully listed on the Shanghai Stock Exchange. Through unremitting efforts, Xinhua medical has become the first enterprise with national enterprise technology center and the only "AAAA" level standardized good behavior in the medical device industry. In 2009, "Xinhua medical" was recognized as "China famous trademark" by the State Administration of industry and commerce. In recent years, the company has undertaken 6 national torch plans, 13 national level 2 new products, more than 300 national patent certificates, won many provincial and municipal science and technology progress awards, and passed ISO9001, ISO13485, CE and other quality system certification. In the process of development, the company has received strong support and concern from governments and leaders at all levels. General Secretary Hu Jintao, Premier Wen Jiabao, vice chairmen Wang Zhaoguo and Li Jianguo and other national leaders first and then inspected the company. On October 17, 2009, General Secretary Hu Jintao came to Xinhua medical inspection. General Secretary Hu expressed his appreciation for the independent innovation of Xinhua medical, and encouraged the employees to continue to forge ahead, constantly promote technological innovation, management innovation and service innovation, so that the enterprise will always maintain vitality. On June 27, 2009, Premier Wen Jiabao came to Xinhua for inspection and guidance. Premier Wen pointed out that the state will continue to strengthen the people's medical and health security capacity. Premier Wen hoped that Xinhua medical could develop faster and better and make greater contributions to the medical cause of the people. Xinhua medical takes "heart health, integrity world" as the enterprise concept and customer satisfaction as our pursuit. The product sales and service network covers all provinces, autonomous regions and municipalities directly under the central government, and is exported to more than 70 countries and regions in Europe, the United States, the Middle East and so on. "Travel far from you, the pursuit of endless.". Xinhua medical will keep pace with the times as always, make contributions to the cause of human health, and forge a monument for China's medical device industry!

本文链接: https://brand.waitui.com/b52e5247b.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

LPR“按兵不动”,后续仍有下行空间

7月21日,中国人民银行授权全国银行间同业拆借中心公布新一期贷款市场报价利率(LPR),1年期为3.0%,5年期以上为3.5%,均与上期持平。业内专家表示,本月LPR维持不变符合市场预期。在大力提振内需等因素下,后续LPR仍有下行空间。(中证网)

2小时前

阿里通义千问宣布更新旗舰版Qwen3模型

阿里通义千问宣布更新旗舰版Qwen3模型,推出Qwen3-235B-A22B-FP8非思考模式(Non-thinking)的更新版本,命名为Qwen3-235B-A22B-Instruct-2507-FP8。本次更新的Qwen3模型,长文本提升到256K。目前,Qwen3新模型已在魔搭社区和HuggingFace上开源更新。(第一财经)

2小时前

优必选:拟折让约9.14%配售新H股,净筹约24.10亿港元

36氪获悉,优必选公告,于2025年7月22日(联交所交易时段前),公司与配售代理订立配售协议,据此,公司已同意委任配售代理,而配售代理已同意按尽力基准,个别(但非共同或共同及个别)作为公司的代理,促使认购方按配售价认购合共3015.5450万股新H股。配售价为每股82.00港元,较于2025年7月21日在联交所所报收市价折让约9.14%。经扣除相关费用及开支,公司将自配售事项收取的所得款项总额及所得款项净额估计分别约为24.7275亿港元及24.1026亿港元。

2小时前

公募基金集中重仓行业龙头个股,对核心资产长期信心不变

Wind数据显示,二季度多只行业龙头个股获得公募基金集中配置,从行业所属分类来看,制造业和消费资产成为配置核心;信息技术行业持仓显著提升,反映出对科技创新类标的的乐观预期。分析人士认为,当前中国经济稳步向好,龙头企业受益于产业升级和消费升级趋势,支撑其盈利稳定性;市场表现上,A股核心资产具有高流动性和低波动性特征,吸引避险资金流入,加之政策和监管环境持续优化,如鼓励科技创新和消费提振,增强投资者对龙头股的配置意愿;行业和板块配置方面,基金偏好高ROE和稳定分红的资产,以平衡组合风险。(证券日报)

2小时前

华泰证券:乳制品行业2026年有望迎来供需拐点

36氪获悉,华泰证券研报表示,中国奶业周期正处于奶价低迷带动上游养殖业持续去产能、下游乳品企业渠道库存去化到位、静待终端需求复苏的基本面左侧,预计在原奶产量下降及乳制品终端需求温和改善的供需关系重塑下,行业有望2026年重回供需平衡,届时原奶价格上涨将对上游牧业企业的利润和股价形成直接催化;因乳品产业链市值大幅集中于下游乳制品企业,历史周期表明奶价温和上涨利于下游企业毛销差改善和利润率提升,目前两大龙头也默契进入提升利润诉求阶段。

2小时前

本页详细列出关于新华的品牌信息,含品牌所属公司介绍,新华所处行业的品牌地位及优势。
咨询